Contracts › FA282323F0022
FA282323F0022: Red Blood Cell Reagents
Awarded to Alba Bioscience, Inc. by Department of the Air Force.
$63Kobligated
$79Kpotential value
30 November 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | FA282323F0022 |
|---|---|
| Vehicle | 36F79721D0259 |
| Awardee | Alba Bioscience, Inc. |
| Awarding agency | Department of the Air Force |
| Awarding office | FA2823 AFTC PZIO |
| NAICS | 325413 In-Vitro Diagnostic Substance Manufacturing |
| PSC | Q301 Reference Laboratory Testing |
| Place of performance | FL |
| Offers received | 1 |
| Period of performance | 02 December 2022 to 30 November 2026 |
| Potential end | 30 November 2027 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325413 contracts · All expiring contracts · USASpending record